Experiment 387862
Worktypes
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Empty organism |
| Citation | NERI,B: DE LEONARDIS,V: GEMELLI,MT: DI LORO,F: MOTTOLA,A: PONCHIETTI,R: RAUGEI,A: CINI,G:. (1998). MELATONIN AS BIOLOGICAL RESPONSE MODIFIER IN CANCER PATIENTS.. 18(2B) |
| Amount utilized | |
| Compound isolated | |
| Disease | ADMINISTRATION OF MELATONIN TO 31 PATIENTS WITH ADVANCED SOLID TUMORS AND UNRESPONSIVE TO CHEMOTHERAPY AND RADIOTHERAPY INCREASED THE LEVEL OF TNF-ALPHA 22%, IL-1 38%, IL-2 41% AND IFN-GAMMA 34%. |
| Dose amount | 10.0 MG |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | PERSON |
| Dose expression | DOSE |
| Gender | GIVEN TO BOTH SEXES |